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Introduction: Head and neck cancer (HNC) patients show a high risk of malnutrition
due to the lifestyle habits adopted prior to the diagnosis as well as to the compromising
impact of both the anatomical location of the tumor and the treatment modalities on food
intake. Weight change, measurement of skinfold thickness, biochemical parameters,
bioelectrical impedance analysis (BIA), computed tomography (CT), magnetic resonance
(MRI), or dual-energy x-ray absorptiometry (DXA) are available techniques to evaluate
nutritional status and/or body composition in the clinical practice. Evaluating body
composition alterations in HNC patients is essential to be able to offer the best
therapeutical interventions. In this paper, we review the existing literature regarding body
composition evaluation in HNC patients to determine, which is the most suitable method
for this population, regarding availability in the day-to-day practice, patient burden, cost,
sensibility, and specificity.
Methodology: A literature search for relevant papers indexed in MEDLINE, Cochrane
Library and Scielo was conducted, with no publication date restriction and for all
published articles until the 31 January, 2019. All the papers written in English, with
interventions in humans, exclusively considering HNC patients were selected.
Results: A total of 41 studies with different methodologies were included in this review.
In 15 studies BIA was the used assessment method and three of them also evaluated
skinfold thickness and one was a bioelectric impedance vector analysis (BIVA). Body
composition assessment was made with DXA in eight studies, one of which also included
muscle biopsies. In two studies the chosen method was both BIA and DXA. CT/ positron
emission tomography-CT was applied in 11 studies and one also included MRI. In two
studies body composition was assessed with skinfold measurements alone and one
study only used BIVA.
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Conclusions: Despite the different existing body composition assessment tools, it
seems that skeletal muscle mass (SMM) measurement at the level of cervical spine
C3 vertebra may be a reliable method for SMM assessment as it strongly correlates
with cross-sectional area measures at the level of L3 and it allows a cost-effective body
composition assessment without the need for additional radiation exposure.
Keywords: head and neck cancer, body composition, cachexia, lean body mass, BIA, DXA, CT
INTRODUCTION
Head and neck cancer (HNC) is responsible for∼300.000 annual
deaths worldwide, with a 40–50% survival rate (1). Beside the
hypercatabolic characteristics of cancer, HNC patients show
a high risk of malnutrition due to the lifestyle habits, such
as smoking and alcohol consumption, adopted prior to the
diagnosis as well as to the compromising impact that both the
anatomical location of the tumor and the various treatment
modalities may have on food intake (2, 3). It is estimated that
about 60% of these patients show poor nutritional status and
about 80% lose weight during treatment (2, 3). Malnourished
patients have a higher risk of infection, delayed wound healing,
impaired cardiac and respiratory function, muscular weakness,
depression, poor quality of life, higher rate of postoperative
complications, higher risk of refeeding syndrome, impaired
response to treatments, higher mortality rate as well as longer
hospitalization time (2). In order to counter malnutrition, its’
early detection is critical.
Some authors suggest that ∼70% of the weight loss identified
in HNC patients corresponds to lean body mass (LBM) (4–6).
Loss of LBM has been presented as an important prognostic
factor (4, 7) with influence in treatment toxicities (8), risk of
recurrence and mortality (9), impaired muscle strength, a decline
in physical activity and functional performance (6). It seems that,
in HNC patients, LBM depletion may provide additional and
relevant information as an outcome predictor beside weight loss
alone and furthermore, high BMI, and low LBM may associate
with each other (10). For these reasons, considering LBM as
a predictor of clinical outcome would take into account also
patients with sarcopenic obesity (11). The main component of
LBM is skeletal muscle mass (SMM). Sarcopenia is characterized
by low SMM combined with low muscle strength or low physical
performance, may be highly prevalent in HNC patients (12). Low
SMM seems to have the most significant impact on the incidence
of complications, prolonged hospital stay, lower overall survival,
lower disease-free survival, and decreased survival in surgical
oncology (13).
Weight loss alone cannot predict LBM loss (14), and several
studies have underlined the importance of body composition
evaluation in HNC patients (8). Besides questionnaires like
Patient-Generated Subjective Global Assessment (PG-SGA)
that allow the assessment of the nutritional status, weight
change, measurement of skinfold thickness, bioelectrical
impedance analysis (BIA), computed tomography (CT),
magnetic resonance (MRI), or dual-energy x-ray absorptiometry
(DXA) are techniques to evaluate nutritional status and/or body
composition (10). DXA is considered the gold standard for total
body composition analysis (8, 15), but it is a medical exam and
not a regular part of the treatment and assessment protocol for
HNC patients (10, 12).
Evaluating body composition alterations in HNC patients is
essential in order to establish the best therapeutical intervention,
but is also a challenging task. We review the existing literature
regarding body composition evaluation in HNC patients to
determine the most suitable method for this population,
regarding availability in the routine clinical practice, patient
burden, cost, sensibility, and specificity.
METHODOLOGY
A literature search for relevant papers indexed in MEDLINE,
Cochrane Library and Scielo was conducted, with no publication
date restriction and for all published articles until the 31 January
2019. All the papers wrote in English, with interventions in
humans, exclusively considering HNC patients, were selected.
Figure 1 describes the selection process of articles. The following
conjugated search terms were used: head and neck cancer OR
larynx cancer OR hypopharynx cancer OR oropharynx cancer
OR lip cancer OR oral cavity cancer or salivary gland cancer
OR nasopharynx cancer OR nasal cavity cancer OR paranasal
sinus cancer OR middle ear cancer; physical activity; body
composition OR bioelectrical impedance analysis OR phase angle
OR computed tomography OR magnetic resonance OR dual-
energy x-ray absorptiometry OR bioimpedance spectroscopy
OR bioelectrical impedance spectroscopy OR BIS OR multiple-
frequency BIA OR MFBIA, MF-BIA OR single-frequency OR
SFBIA OR BIVA OR bioimpedance vector analysis OR SF-
BIA OR bioelectrical impedance vector analysis OR magnetic
resonance imaging OR MRI or MRI Scan OR CT scan OR
computed tomography scan OR computed axila tomography
scan OR DEXA or DXA or CT imaging; LBM OR lean
tissue OR FFM OR lean soft tissue OR fat mass OR
anthropometric assessment OR body cell mass assessment OR
intracellular water.
The first selection of articles was based on the titles
and abstracts, and then full texts were evaluated. All the
articles that included body composition evaluation using BIA,
MRI, CT, DXA, or skinfold measures, in HNC patients over
18 years old, were included in this review. The articles
only considering BMI or with body composition evaluations
in a population with other cancer sites than the head
and neck area, were not included. All study designs were
included. Data were collected from each individual study and
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FIGURE 1 | Flow diagram of the study selection process.
then systematically recorded in a document that included
the following parameters: author, study methodology, study
objectives, number of participants, mean age, gender, cancer
stage, treatment, median BMI, inclusion and exclusion criteria,
body composition assessment (technique, variables assessed,
assessment timing), study limitations and conclusions.
RESULTS
The search of the databases MEDLINE, Cochrane Library and
Scielo, resulted in 932 records. After removal of duplicate papers,
848 records were screened, ten papers were found by consulting
the references of the screened papers, and after excluding the
studies that did notmeet the inclusion criteria, 59 full-text articles
were assessed for eligibility, 18 of which were excluded for the
following reasons:
- Only describing study protocol (n= 2);
- Only assessing nutritional status and not body composition
(n= 4);
- Only assessing phase-angle variations during radiotherapy
(RT) (n= 1);
- Study population including multiple cancer sites (n= 1);
- The final version of the submitted article was not accessible
(n= 3).
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A total of 41 studies were included in this review, with different
methodologies: one systematic review (16), one consensus paper
(17), one data descriptor (18), nine randomized trials (6, 11, 19–
25), 12 cohort studies (3, 7–9, 15, 26–32), three randomized
controlled trials (4, 5, 33), three cross-sectional studies (34–
36), two prospective non-randomized trials (37, 38), eight
retrospective studies (10, 12–14, 39–42), and one case-control
study (43).
Population
The studies included in this review comprised a total of 2,708
participants, 81% were male, and 19% female, with a mean age
ranging between 46 and 66 years. Only one study included just
male participants (40). The mean baseline BMI ranged from 19.5
to 29.6 kg/m2.
Themost frequent exclusion criteria were comorbidities (liver,
kidney or cardiac disease, chronic obstructive pulmonary disease,
muscular disease, or uncontrolled diabetes mellitus), metastatic
disease, treatment with steroids and other malignancies.
Body Composition Assessment
In 15 studies BIA was the assessment method used (3, 5,
7, 8, 20, 21, 23–26, 30, 33, 34, 36, 43), three of which also
evaluated skinfolds (23, 25, 30) and one applied bioelectric
impedance vector analysis (BIVA) (42). In eight studies, the body
composition assessment was made with DXA (4, 6, 9, 11, 19, 22,
29, 31), one of which also included muscle biopsies (9). In two
studies, the chosen method was both BIA and DXA (27, 28). CT/
positron-emission tomography-CT (PET-CT) was applied in 11
studies (10, 12–15, 18, 32, 39–42) and one also included MRI
(39). In two studies, body composition was assessed with skinfold
measures alone (35, 38), one of which also used circumferences
(35) and one study only used BIVA (37).
Considering the studies that assessed the patients’ body
composition with CT/PET, five used the 3rd lumbar vertebra (L3)
(10, 14, 18, 32, 42) as a landmark point, one used the 4th lumbar
vertebra (L4) (15) and five used the 3rd cervical vertebra (C3)
(12, 13, 39–41).
Swartz et al. (12) found a good correlation between the L3
muscle cross-sectional area (CSA) and the C3 muscle CSA in the
evaluation of SMM and the method used by these authors was
replicated in two other studies (40, 41).
In the studies using C3 as the reference point and calculating
the cross-sectional area at L3 (39, 41), the cut-off point for low
SMM was <43.2 cm2/m2, and CSA at L3 was calculated with
the formula:
CSA at L3 (cm2) = 27.304 + 1.363∗CSA at C3
(cm2)−0.671∗Age (years) + 0.640∗Weight (kg) + 26.442∗Sex
(Sex= 1 for female, 2 for male).
One study (40) considered the PVM CSA below 815
mm2/m2 as a potential prognostic indicator of postoperative
wound complications.
Among the studies using BIA as an assessment method, seven
did not report the frequencies applied (3, 5, 8, 21, 26, 28, 37);
eight used a frequency of 50 kHz (7, 23–25, 30, 33, 34, 43) and
three also used other frequencies besides 50 kHz (20, 27, 36).
Only two studies mentioned the equations used in the LBM
and FBM (Fat Body Mass) calculations (7, 27). None of the
studies referred to complications having an association with any
of the methods used in the evaluations, such as pain, discomfort,
nausea, or dyspnea.
Tables 1–5 resume the information regarding the body
composition assessment methods of each study included in
this review.
DISCUSSION
Establishing a reliable and easy to use method for body
composition assessment in clinical settings remains a challenge.
The studies included in this literary review comprised
heterogeneous methodologies, objectives as well as methods
to assess body composition in HNC patients, which makes
it difficult to compare them. We present a review of the
existing evidence.
Formula-based body composition assessment (using the
Hume formula, Boer formula, and James formula) failed to
accurately estimate LBM in HNC patients submitted to radiation
treatment when the results were compared with the ones
obtained through CT image-based evaluation of L3 (10).
Anthropometry
Anthropometric measures are widely available, easy to assess
and inexpensive. Although it is known that BMI is not sensitive
to body composition variations and that in obese populations,
it is a poor predictor of muscle mass (10), it is still widely
used in clinical settings (44). BMI was also evaluated in all the
studies included in this review, and its variations during cancer
treatments were reported.With the increase in obesity prevalence
in the HNC patient population (10), and as it seems that weight
loss alone cannot predict LBM loss (8), methods allowing a more
detailed evaluation are needed.
Skinfold thickness measurement allows evaluating
subcutaneous fat in sites such as biceps, triceps, subscapular,
and supra iliac area using a caliper. One study (38) used it as a
single method to assess body composition and aimed to compare
33 patients randomized between a group with a percutaneous
endoscopic gastrostomy tube (PEG) and a group with a
nasogastric tube for feeding evaluation purposes. Although the
authors did not refer to any limitations related to the assessment
method, it is known to be sensitive to technician skills, type of
caliper and prediction equations used (44). One other study
(35) used both skinfold thickness and mid-upper arm (MUAC)
and mid-arm muscle circumference (MAMC), to evaluate the
outcome and nutritional status at the time of the procedure, of
234 patients who underwent PEG, as well as the association of
nutritional status/outcome, creating a predictive survival model.
Low MUAC was present in 84% of the patients, and low MAMC
was present in 75% of the patients. The authors mention that the
slow changes of the anthropometric measurements may make
this method inadequate to perceive malnutrition early.
BIA
Prediction of body composition based on the electrically
conductive properties of both lean tissue (good electrical
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TABLE 1 | Body composition assessment: CT scan.
References Study objective Participants (n) Gender (n/%) Mean age ± SD Reference
point
Software
Nejatinamini et al. (32) To investigate how vitamin status prior to and after cancer
treatment in patients with HNC relates to BC, mucositis, and
systemic inflammation
28 M: 23 (82%)
F: 5 (18%)
60.3 ± 10.8 L3 Slice-O-Matic software (Slice-O-Matic version 4.3,
TomoVision, Magog, QC, Canada)
Grossberg et al. (14) Characterize the association between skeletal muscle mass
depletion and HNSCC survival. Identify and compare the
prognostic significance of LBM, weight loss, and BMI on
locoregional control and survival
190 M: 160 (84.2%)
F: 30 (15.8%)
57.7 ± 9.4 L3 Image-processing platform: Pinnacle 9.6; Philips
Medical Systems
Wang et al. (15) Characterize the changes in body morphomics (total psoas
area, lean psoas area, psoas muscle density, HU) before and
after chemoradiotherapy by determining the association
between these changes with patient-reported quality of life
and tumor related outcomes. To determine whether changes
in psoas area correlate with changes in total BC as
determined by DXA scan
DXA study: 12
BM study: 43
Total: 55
DXA study M: 12
(100%)
BM study M: 36
(95%)
F: 2 (5%)
DXA study:
57 ± 8.1
BM study:
57 ± 7
L4 MATLAB v13.0
Chamchod et al. (10) To determine whether formula-based body composition
assessment is sufficient as standard practice in the initial
work-up and post-therapy surveillance of HNC patients
215 M: 184 (85%)
F: 31 (14.4%)
57.21 ± 9.79 L3 Pinnacle 9.6, Philips Medical Systems, Andover, MA
Bril et al. (39) To investigate whether preoperative low SMM, as measured
using CT or MRI at the level of C3, is a significant predictor of
postoperative complications
235 M: 193 (82.1%)
F: 42 (17.9%)
64.7 ± 9.1 C3 Software package SliceOmatic (Tomovision, Magog,
Quebec, Canada)
Bril et al. (13) To evaluate the interobserver agreement of SMM
measurement at the level of C3
54 M: 36 (66.7%)
F: 18 (33.3%)
56.8 ± 7.3 C3 Philips Brilliance iCT scanner (Philips Healthcare,
Best, The Netherlands)
Swartz et al. (12) To investigate whether SMM may be assessed on a routine
head and neck CT
52 M: 34 (66.7%)
F: 17 (33.3%)
61.9 ± 10.5 C3 Volumetool Research software package
Bozkurt et al. (40) To investigate the relationship between paravertebral muscle
cross-sectional area at C3 using CT neck images and
complications in advanced laryngeal cancer patients
60 M: 60 (100%) 59.37 ± 8.4 C3 PACS, Infinit Healthcare, South Korea, Guro-gu
The CSAs within the limits of the drawn boundaries
were calculated using Xelis 3D software (V1.0.6.1, Infinit
Healthcare, South Korea, Guro-gu)
Wendrich et al. (41) To investigate the predictive value of low SMM on
chemotherapy dose-limiting toxicity in locally advanced head
and neck squamous cell carcinoma patients treated with
primary radiochemotherapy. To determine whether low SMM
is related to overall survival
112 M: 72 (64.3%)
F: 40 (35.7%)
54.5 ± 9.4 C3 Volumetool Research software package
Nishikawa et al. (42) To investigate the prognostic impact of skeletal muscle
depletion and sarcopenia on HNC patients
85 M: 66 (78%)
F: 19 (22%)
66 L3 Digital Imaging and Communication in Medicine
(DICOM) form
ImageJ software v1.44p (National Institutes of
Health, Bethesda, MD, USA)
Grossberg et al. (18) To detail the collection and processing of computed
tomography based imaging in 215 patients with HNSCC that
were treated with radiotherapy
215 M: 182 (85.5%)
F: 33 (15%)
57.2 PET-CT
(whole-body)
CT (Abdominal
- L3)
Pinnacle 9.6; Philips Medical Systems
BC, body composition; BMI, body mass index; C3, 3rd cervical vertebra; CSA, cross-sectional area; CT, computed tomography; DXA, dual-energy X-ray absorptiometry; F, female; HNC, head and neck cancer; HNSCC, head and neck
squamous cell; L3, 3rd lumbar vertebra; L4, 4th lumbar vertebra; LBM, lean body mass; M, Male; MRI, magnetic resonance imaging; PET; positron emission tomography; SMM, skeletal muscle mass.
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TABLE 2 | Body composition assessment: DXA.
References Study objective Participants (n) Gender (n/%) Mean age ± SD DXA
Capozzi et al. (19) To determine the optimal timing for initiation of physical
activity intervention
60 M: 49 (81.7%)
F: 11 (18.3%)
55.9 ± 9.2 Hologic QDR 4500; Hologic Inc., Bed- ford, MA
Hologic QDR software
Jackson et al. (4) Characterize changes in total BC for patients undergoing
concurrent chemoradiation
Correlate changes in total BC with hydration status
through analysis of serum creatinine levels
12 M: 12 (100%) 57 ± 8.1 iDXA whole body scanner
GE/Lunar Corp, Madison, WI
Silver et al. (29) To investigate changes in BC and energy balance in
patients with HNC undergoing concurrent
chemoradiation treatment, after completion of low-dose
induction chemotherapy
17 M: 15 (88%) 58.9 Lunar Corp Madison, WI
Software version 4.3e
Ng et al. (31) Investigate Nutritional status of nasopharynx cancer
patients before and after RT and the factors affecting it
38 M: 30 (78.9%)
F: 8 (21.1%)
46 QDA 4500 Elite model, Hologic, Inc., Waltham, MA
Lonkvis et al. (9) Test the feasibility of a 12-week PRT.To investigate
whether PRT may ameliorate weight loss and loss of
LBM, maintain muscle strength and functional
performance in HNSCC patients
12 M: 7 (58%)
F: 5 (42%)
56 GE lunar iDXA, GE Healthcare Technologies, Madison,
Wisconsin, US
Software version 14.10
Lønbro et al. (6) To investigate the effects of PRT on LBM in a
randomized trial in HNSCC patients following RT
41 Early exercise: F:
5 (31%) M:
11 (69%) Delayed
exercise F: 2 (14%)
M: 12 (86%)
Early Exercise: 52
± 7
Delayed Exercise:
58 ± 7
Lunar Prodigy Advance, GE Healthcare Technologies,
Madison, WI, USA
Scan Analyses: Prodigy enCORE software
Lønbro et al. (11) To investigate the associations between LBM, maximal
muscle strength and functional performance
To compare baseline and post-training values of these
variables of HNSCC patients to values of
healthy individuals
55 HNC (24
healthy individuals)
M: 54 (82%)
F: 12 (18%)
56 ± 8 Lunar Prodigy Advance, GE Healthcare Technologies,
Madison, WI, USA
Scan Analyses: Prodigy enCORE software
Lønbro et al. (22) To investigate the feasibility of whole body PRT program,
protein and creatine supplementation
To investigate group changes over time and group
differences regarding LBM, muscle strength and
functional performance
30 M:23 (76.7%)
F: 7 (23.3%)
PROCR group: 56
PLA group: 59
Lunar Prodigy Advance, GE Healthcare Technologies,
Madison, WI, USA
Software: Prodigy enCORE
Wang et al. (15) Characterize the changes in body morphomics (total
psoas area, lean psoas area, psoas muscle density, HU)
before and after chemoradiotherapy by determining the
association between these changes with
patient-reported quality of life and tumor related
outcomes
To determine whether changes in psoas area correlate
with changes in total BC as determined by DXA scan
DXA study: 12
BM study: 43
Total: 55
DXA study M: 12
(100%)
BM study M: 36
(95%)
F: 2 (5%)
DXA study: 57 ±
8.1
BM study: 57 ± 7
MATLAB v13.0
BC, body composition; DXA, dual-energy X-ray absorptiometry; HNC, head and neck cancer; HNSCC, head and neck squamous cell carcinoma; LBM, lean body mass; PRT, progressive resistance training program; RT, radiotherapy.
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TABLE 3 | Body composition assessment: review articles.
References Study objective Articles Body composition
(BC) assessment
Methods
Dechaphunkul
et al. (17)
Review the literature on HNC to understand how
malnutrition and cachexia are defined by
researchers publishing in this field
117 articles
(14,772
participants)
12/117 articles
assessed BC
BIA (n = 7), DXA (n = 1), anthropometry (n = 8)
Capozzi et al.
(16)
To systematically summarize the HNC and physical
activity literature
16 articles
(1,582
participants)
8/16 articles
assessed BC
BMI (n = 5), DXA (n = 4), BIA (n = 1),
anthropometry (n = 1)
BC, Body composition; BIA, Bioelectrical impedance analysis; BMI, Body mass index; DEXA, Dual-energy X-ray absorptiometry; HNC, Head and neck cancer.
conductor) and fat mass (poor electrical conductor due to
the absence of water) is the principle of BIA (44, 45). BIA
measures can use single-frequency (SF), which passes through
the extracellular fluid or multi-frequency current (MF), which
passes through both the extracellular and the intracellular fluid.
BIA is an indirect (43) and quick (7) method that estimates total
body water (TBW) and through this estimation determines LBM,
assuming a constant hydration factor of 73% (33). Fat body mass
is calculated from the weight difference between LBM and body
weight (33). It is a validated method to assess body composition
in patients with cancer (26, 36) and was used in 17 studies in
this review.
Both BIA and skinfold measurements were used in three
studies (23, 25, 30) that assessed the changes in body composition
and nutritional status during cancer treatment with (23, 25)
or without (30) nutrition interventions. Foot-to-foot BIA was
used by Isenring et al. (21). Despite providing some additional
information when compared to BMI or weight loss, it is a
method that does not measure the entire body (46) and for that
reason gives incomplete information. BIA and BIVA were both
used in one study (34), and one other study only used BIVA
(37). BIVA is a qualitative evaluation method of hydration, cell
integrity and body cell mass that can contribute with additional
information to BIA measures. It seems that this (34) was the
first study in the population of HNC patients to include BIVA
measures. The authors concluded that both BIA and BIVA are
useful tools in the assessment of body composition. BIA is
an inexpensive method when compared to more sophisticated
ones, easy-to-use, non-invasive, and reproducible (26). It has
been considered to have good consistency (particularly FFM)
in evaluating body composition during HNC treatments (8).
However, to enhance accuracy in LBM variations, the evaluations
should be done under the same circumstances and taking into
consideration an adequate fluid balance (33, 46) and food intake
(33). The following possible sources of error should be taken into
account: nutrition status, physical activity, phase of themenstrual
cycle, placement of electrodes, limb length, blood chemistry (44),
altered fluid balance, edema, endocrine diseases that influence
body composition, treatment with growth hormone, acute illness,
intensive care treatment, organ transplantation, position of the
body, and movements during the measure, type of electrodes,
use of oral contraceptives (46). This method also loses accuracy
when patients are in the extremes of BMI ranges (<= 16
kg/m2 or >= 35 kg/m2) (7, 46) and although at baseline
the patients of the studies included in this review had BMI
classifications ranging between normal weight and pre-obesity
(with the mean BMI ranging from 21.8 to 29.6 kg/m2), it
can be a significant limitation in a population susceptible
to weight loss during treatments, as HNC patients are (8).
Regarding the hydration status, dehydration, or overhydration
may underestimate or overestimate LBM or FBM (46), and the
studies results are heterogeneous. Luis et al. (43), identified
altered electric properties of the tissues in a population of 32
HNC men, but a total body hydration disorder was excluded
when comparing the resistance (R) component with one of
healthy subjects. On the other hand, Malecka-Massalska et al.
(36) mentions a higher electric current resistance due to a smaller
distribution of water between the extracellular and intracellular
compartments in HNC patients. As an indirect method, it
relies on a large number of prediction equations using linear
regression to estimate body composition based on a variety
of predetermined variables that may differ between different
populations and were derived from healthy individuals (46).
Two studies (27, 28) in this review used BIA and DXA. One
aimed (27) to validate BIA using Geneva equation to assess
LBM in 35 HNC patients. In this study, three frequencies
were used (5, 50, and 200 kHz) at three-time points (before
the start of cancer treatment, 1 and 4 months after the end
of treatment). Each BIA measurement was followed by a DXA
scan, and the authors only found a slight underestimation
(without statistical significance) of LBM using BIA with Geneva
equation and considered that this method is acceptable for LBM
assessment in this population. The other study was a prospective
cohort study with 29 HNC patients. The authors evaluated
if the nutritional status changed during HNC treatment. The
same previously mentioned three-time points were evaluated,
and the alterations in LBM and FBM were registered. No
comparison was made between the results obtained with the
two methods.
The tendency toward underestimation of both TBW
and LBM has already been identified (45, 46). In
regards to the oncological patients, Haverkort et al.
(46) concluded that BIA estimations could be useful if
used longitudinally.
Taking into consideration rawmeasurements like R, reactance
(X) and phase angle can be an advantage in situations in which
the equations do not apply as well as to evaluate tissue hydration
status (43, 46). This is important as it seems that different BIA
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TABLE 4 | Body composition assessment: BIA.
References Study objective Participants
(n)
Gender (n/%) Mean age
± SD
BIA model Frequencies
(kHz)
Equation Description
of BIA
protocol
Axelsson et al. (7) Investigate whether bioelectrical phase angle and
standardized phase angle were predictive for survival
in advanced HNC
128 M: 87 (68%)
F: 41 (32%)
61.4 ± 10.0 Model BIA-101S Akern: RJL Systems,
Detroit, MI, USA
50 Lukaski
equation
Yes
Lundberg et al. (34) Describing a cohort of Finnish HNC patients at
cancer presentation by medical BIA
41 M: 32 (78%)
F: 9 (22%)
62.5 Seca mBCA 515 50 Unknown No
Solís-Martínez et al. (5) Assess the effect of the administration of 2 g daily
dose of EPA on body composition and inflammation
markers in patients with HNSCC during
antineoplastic treatment
64 M: 35 (54.6%)
F: 29 (46.4%)
58 RJL system using Quantum model IV
BC Body Composition Software
Unknown Unknown No
Carvalho et al. (30) Examine the involvement of antitumor treatment,
including surgical resection and/or CRT, in the
nutritional and metabolic status of patients with
HNSCC
32 M: 31 (97%)
F: 1 (3%)
NA BIA 310; Biodynamics, Seattle, WA Unknown Unknown Yes
Della Valle et al. (37) Evaluate the impact of an early nutritional intervention
in patients with HNC with prophylactic gastrostomy
undergoing CRT on body weight and body
composition
35 M: 20 (57.1%)
F: 15 (42.9%)
60 EFG model Akern, Florence, Italy Unknown Unknown No
Weed et al. (20) Assess the safety and tolerance, as well as the
preoperative and postoperative impact of
consumption of EPA-containing supplement on
weight and BC in adult patients with HNC–related
weight loss undergoing treatment with curative intent
31 M: 23 (74.2%)
F: 8 (25.8%)
62 BodyStat’s Quadscan
BodyStat Ltd., Douglas, United Kingdom
5, 50, 150,
200
Standard Manufacturer
instructions
Arribas et al. (8) To evaluate the changes in BC and nutritional status
that occur throughout the oncological treatment in
HNSCC patients
20 M: 19 (95%)
F: 1 (5%)
53.7 ± 7.11 TANITA BC-418MA segmental
Biológica tecología médica, SL,
Barcelona, Spain
Unknown Unknown Yes
Isenring et al. (21) Compare the change in BC in ambulatory cancer
patients receiving radiotherapy to the head and neck
area with groups receiving nutrition intervention or
usual care
32 M: 29 (91%)
F: 3 (9%)
63 ± 15 BIA foot-to-foot Unknown Standard No
Hopanci Bicakli et al.
(3)
To evaluate the effect of compliance with individual
dietary counseling provided by the dietitian on BC
and anthropometry in HNC patients under RT
59 M: 47 (79.7%)
F: 12 (20.3%)
61 ± 13.8 TANITA (Tanita Body Composition Analyzer
SC 330 Japan)
Unknown Unknown No
Ding et al. (26) To investigate the longitudinal BC changes in
patients with nasopharyngeal carcinoma undergoing
CRT. To compare the use of the PG-SGA and the
ESPEN diagnostic criteria, in order to explore better
BC parameters that could be valuable in diagnosing
malnutrition in nasopharyngeal oncology settings
48 M: 36 (75%)
F: 12 (25%)
47 nBody S10 Biospace device
Biospace Co, Ltd, Seoul,
Korea/Model JMW140
Unknown Unknown Yes
(Continued)
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TABLE 4 | Continued
References Study objective Participants
(n)
Gender (n/%) Mean age
± SD
BIA model Frequencies
(kHz)
Equation Description
of BIA
protocol
Grote et al. (33) To determine the practicability of recruitment and the
feasibility of progressive resistance training during RT
for cachectic HNC patients
20 M: 15 (75%)
F: 5 (25%)
60.9 ± 11.3 AKERN SRL, BIA 101 New Edition 50 Unknown Yes
Malecka-Massalska
et al. (35)
To perform BIA to investigate tissue electrical
properties in patients diagnosed with HNC before
surgery
31 M: 28 (90.3%)
F: 3 (9.7%)
57.9 ± 8.0 iMed bioimpedance analysis SFB7 BioImp,
v 1.55
Pinkenba Qld 4008, Australia
5, 50, 100,
200
Unknown Yes
Luis et al. (24) To investigate whether postoperative nutrition of
HNC patients, using a higher dose of arginine (17
g/day) enhanced diet, could improve nutritional
variables as well as clinical outcomes, when
compared with a control enteral diet
72 M: 65 (90.3%)
F: 7 (9.7%)
Group I:
62.1 ± 12
Group II:
61.5 ± 11
Biodynamics Model 310e, Seattle, WA 50 Unknown Yes
Luis et al. (43) To investigate in a case-control study the utility of
phase angle and other impedance parameters in a
population of male patients with HNC
67 M: 67 (100%) 58.49 ±
14.54
Biodynamics Model 310e, Seattle, WA 50 Unknown Yes
Luis et al. (25) To investigate whether oral ambulatory nutrition of
HNC patients, using an 3 fatty acid (low ratio 6/3
fatty acids)-enhanced diet versus an oral
arginine-enhanced formula, could improve nutritional
variables as well as clinical outcome, postoperative
infectious and wound complications
73 M: 68 (93.2%)
F: 5 (6.8%)
Group I:
60.2 ±
11.15
Group II:
62.5 ± 11.4
Biodynamics Model 310e, Seattle, WA 50 Unknown Yes
Luis et al. (23) To investigate whether oral ambulatory nutrition of
postsurgical HNC patients with recent weight loss,
using two different omega 3 fatty acids enhanced
diets could improve nutritional variables as well as
clinical outcome
65 M: 59 (90.8%) F: 6
(9.2%)
Group I:
63.9 ± 11.2
Group II:
62.8 ± 11.4
Biodynamics Model 310e, Seattle, WA 50 Unknown Yes
Jager-Wittenaar et al.
(27)
Test the validity of BIA using Geneva equation to
assess fat free mass in patients with HNC in
pretreatment and post treatment periods
24 M: 20 (83%)
F: 4 (17%)
60.4 ± 8.3 Bodystat QuadS-can 4000 (Bodystat) 5, 50, 200 Geneva
equation
Yes
Jager-Wittenaar et al.
(28)
Test whether nutritional status, including lean body
mass, changes during and after HNC treatment
including RT or chemoradiation
29 M: 23 (79%)
F: 6 (21%)
60.6 ± 10.0 Bodystat QuadS-can 4000 (Bodystat) Unknown Unknown Yes
BC, body composition, BIA, bioelectrical impedance analysis, CRT, chemoradiotherapy, EPA, eicosapentaenoic acid, ESPEN, European Society for Clinical Nutrition and Metabolism, F, female, HNC, head and neck cancer, HNSCC,
head and neck squamous cell cancer, M, male, PG-SGA, Patient-Generated Subjective Global Assessment, RT, radiotherapy.
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TABLE 5 | Body composition assessment: Anthropometry.
References Study objective Participants
(n)
Gender
(n/%)
Mean age ± SD Body composition (BC) assessment
Corry et al. (38) Prospective
non-randomized trial.
33 M: 24 (73%)
F: 9 (27%)
60 Upper arm circumference and triceps skin fold
thickness
Fonseca et al. (36) Cross-sectional 234 M: 211 (90%)
F: 23 (10%)
61.6 Upper arm circumference, mid-arm muscle
circumference and triceps skin fold thickness
F, female; M, male.
TABLE 6 | Advantages and limitations of each body composition assessment method in HNC.
Method Advantages Limitations
Anthropometry Widely available
Easy to assess
Inexpensive
BMI: not sensitive to BC variations; it is a poor predictor of muscle mass in
obese populations
Skinfold thickness: sensitive to technician skills, type of caliper, and
prediction equations used
BIA Indirect method (relies on prediction equations to estimate BC) Quick
Validated to assess BC in patients with cancer Inexpensive
Easy-to-use
Noninvasive
Reproducible
To enhance accuracy in LBM variations, the evaluations should be done
under the same circumstances, and taking into consideration an adequate
fluid balance and food intake
Possible sources of error: nutrition status, physical activity, phase of the
menstrual cycle, placement of electrodes, limb length, blood chemistry,
hydration status, edema, endocrine diseases that influence body
composition, treatment with growth hormone, acute illness, intensive care
treatment, organ transplantation, position of the body and movements
during the measure, type of electrodes, use of oral contraceptives,
extremes of BMI ranges (≤16 or ≥35 kg/m2)
Foot-to-foot BIA: does not measure the entire BC
DXA The gold standard for determining total BC
Validated to assess LBM and BC in cancer patients
Quick Low radiation exposure Little preparation Low technical skills
Hydration status may influence LBM or fat body mass measures
Not routinely performed in the management of HNC
CT L3: one of the reference methods for BC evaluation in cancer patients
C3: routinely performed in the management of HNC
L3: not routinely performed in the management of HNC
C3: few studies are available
BC, body composition; BIA, bioelectrical impedance analysis; BMI, body mass index; C3, 3rd cervical vertebra; CT, computed tomography; DXA, dual-energy X-ray absorptiometry;
HNC, head and neck cancer; L3, 3rd lumbar vertebra; LBM, lean body mass.
devices measuring the entire body, as long as well-calibrated, will
give comparable results. However, more studies will be needed to
evaluate the clinical applicability of these data (45).
DXA
DXA measures regional or total body fat, muscle, and bone
mineral. It is the gold standard for bone density measurements
as well as for determining total body composition (15). It is
also a quick method with low radiation exposure and warrants
only little preparation and low technical skills (44, 45). DXA is a
validated method to assess LBM and body composition in cancer
patients (6).
Five studies (4, 6, 11, 19, 22) assessed body composition
using DXA to assess the results of a progressive resistance
training (PRT) program. The authors reported good feasibility
and no complications.
Jackson et al. (4), noted LBM alterations in clinically
dehydrated patients and mentioned that the variation in LBM
observed on DXA could be a variation in hydration status, as it
seems that DXA has failed to determine if changes in hydration
occurred in LBM or FBM (4). The variation in hydration status
can be a confounding factor, as cancer patients often show fluid
status fluctuations, especially during treatments.
Two studies (29, 31) investigated the body composition
alterations in HNC patients during cancer treatments
and identified the expected decrease in both LBM
and FBM.
A single study used both DXA and muscle biopsy (9), in a
feasibility test of a 12-week PRT program, including 12 HNC
patients. Muscle biopsy was used to analyse further the major
alterations registered in LBM during antineoplastic treatments,
characterizing muscle fiber types and the enzymes metabolic
pathways involved. During treatments, the authors reported
a decrease in LBM even during PRT that reverted after the
completion of the treatments and mentioned that it was a feasible
intervention as a whole and that patients were satisfied with
the program.
CT
CT images are usually part of the routine imaging protocol
before and after treatment (4) and CT images of L3 are
frequently used in studies assessing body composition in
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cancer patients (8, 42), as the cross-sectional area (CSA)
of L3 have a high correlation to whole body muscle mass
(32, 42). It was the chosen method for body composition
assessment in four studies (10, 14, 15, 32), which all had
different objectives.
The images were mostly taken for diagnostic purposes and
after completion of the treatments. The authors of one of the
studies identified a considerable weight loss (7,1 kg) with equal
losses of muscle (3,4 kg) and fat, during cancer treatment (32)
and in another study (14), it was reported that low SMM both
before and after treatment is associated with decreased overall
and cancer-specific survival.
Body morphomics analysis (BMA) was used in one study (15).
It is a CT-based technique that analyses the body composition
and characterizes the changes in regional body composition,
measuring CSA and densities of the psoas muscle. In this
study, the BMA measurements at the level of the L4 were
compared to DXA results. The authors found similar results
between both techniques and univariate analysis revealed that
the total psoas area predicted mortality in oropharyngeal
cancer patients.
CT imaging of the L3 is not routinely performed during
HNC cancer treatments (8, 13, 14). In fact, some studies
pinpoint the exclusion of patients without this exam as a
study limitation (15, 42). CT images at the level of C3
may be a cost-effective and a reliable alternative (12, 39,
41), that have the advantage of being a routinely performed
imaging method in the majority of HNC patients (39) and
in addition causing less radiation exposure and therefore
less patient burden. In our review, this method showed
a significant correlation with L3 measures considering the
sum of paravertebral muscles (PVM) and sternocleidomastoid
muscles (SCM).
Although one study (13) included in this review has found
an excellent interobserver agreement of SMM measurements
at the level of C3 for all CSA measures, the authors advise
the use of a training data set to minimize errors in the
delineation of SMM and single slice selection. The automatic
determination of skeletal muscle area (in a window of −29 to
+150 Hounsfield Unit) should be preferred instead of visual
delineation of the muscles (12), to avoid overestimation of
muscle mass.
Lymph node metastases, which are common in HNC patients
at the time of diagnosis, can impair SCM measurement (12,
40). In one study this limitation was minimized, with good
results, by doubling the area of the SCM that could be measured
(12) and in another study by excluding the SCM from the
CSA calculations, as CSA at L3 correlates with CSA PVM
alone (40).
In Table 6 are resumed the advantages and limitations of each
body composition assessment method in HNC.
LIMITATIONS
This review has some limitations such as the heterogeneity
in methodologies, objectives, and assessment methods of
the included HNC studies. Only a few studies had as the
primary outcome the evaluation of the body composition
and not all the studies included detailed results of the
performed assessments. Regarding the methods used, there
are no validated methods for this specific patient population.
Furthermore, the outcome measures can differ between
different nationalities.
CONCLUSION
This review is a qualitative synthesis of the available
evidence regarding body composition assessment methods
in HNC patients.
The studies included used different body composition
assessment tools, making it challenging to summarize the results.
The reference methods for body composition evaluation in
cancer patients are DXA and CT at L3, but these examinations
are not routinely performed in the management of HNC.
Since variations in body composition in HNC patients are very
prevalent, it is of utmost importance to find a tool with low costs
and with a low burden to the patient.
Despite the different existing body composition assessment
tools, it seems that SMM measurement at the level of C3 may
be a reliable method for SMM assessment as it strongly correlates
with CSA measures at the level of L3 and it allows a cost-effective
body composition assessment without the need for additional
radiation exposure.
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